NDC properties for "Timoptic 0.0025 MG/MG Ophthalmic Gel" (RxCUI 861420)
About this data
The tables show NDC propoerties for Timoptic 0.0025 MG/MG Ophthalmic Gel with the RxCUI 861420
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Timoptic 0.0025 MG/MG Ophthalmic Gel (RxCUI 861420)
| MMSL_CODE | BD3327 |
|---|---|
| NDA | NDA020330 |
| RxCUI | 861420 |
| SPL_SET_ID | a4d03de7-06b7-4cfc-9d1b-616969df209c |
| Prescribable Synonym | Timoptic-XE 0.25 % Ophthalmic Gel Forming Solution |
| RXNAV_STR | Timoptic 0.0025 MG/MG Ophthalmic Gel |
| RxNorm Name | timolol 0.0025 MG/MG Ophthalmic Gel [Timoptic] |
| RxNorm Synonym | Timoptic 0.0025 MG/MG Ophthalmic Gel |
| RxNorm Synonym | Timoptic-XE 0.0025 MG/MG Ophthalmic Gel |
| RxNorm Synonym | Timoptic-XE 0.25 % Gel Forming Solution |
| Related queries | Interactions (for RxCUI 861420) |
NDC Properties
NDC Item 24208081425
| NDC 9 | 24208-814 |
|---|---|
| NDC 10 | 24208-814-25 |
| NDC Item | 24208081425 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (24208-814-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 639370 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2016-05-31 |
| Marketing status | ACTIVE |
| NDA | NDA020330 |
| Related queries | Properties for NDC 9 24208-814 |
NDC Item 25010081056
| NDC 9 | 25010-810 |
|---|---|
| NDC 10 | 25010-810-56 |
| NDC Item | 25010081056 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (25010-810-56) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 282260 |
| Labeler | Bausch Health US, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2017-06-30 |
| Marketing effective time low | 1993-11-14 |
| Marketing status | COMPLETED |
| NDA | NDA020330 |
| Related queries | Properties for NDC 9 25010-810 |
NDC Item 24208081425
| NDC 9 | 24208-814 |
|---|---|
| NDC 10 | 24208-814-25 |
| NDC Item | 24208081425 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (24208-814-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 639370 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2016-05-31 |
| Marketing status | ACTIVE |
| NDA | NDA020330 |
| Related queries | Properties for NDC 9 24208-814 |
NDC Item 25010081056
| NDC 9 | 25010-810 |
|---|---|
| NDC 10 | 25010-810-56 |
| NDC Item | 25010081056 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (25010-810-56) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 282260 |
| Labeler | Bausch Health US, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2017-06-30 |
| Marketing effective time low | 1993-11-14 |
| Marketing status | COMPLETED |
| NDA | NDA020330 |
| Related queries | Properties for NDC 9 25010-810 |